Low vs standard dose valganciclovir
Graft loss · solid organ transplant recipients
Low showed no clear difference in graft loss compared with standard dose valganciclovir (low certainty).
1 finding from 1 review
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 2024 · Cochrane Headline outcomes onlyRR 1 [0.06, 15.76]1 study · 196 participantsLow